Skip to main content
Psoriatic Arthritis ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
Crosswords
Psoriatic Arthritis Treatment Basics
Publish date:
June 13, 2022
Recommended Reading
Meta-analysis evaluates degree of skin involvement in patients with PsA vs only psoriasis
Psoriatic Arthritis ICYMI
PsA: Baseline disease activity predicts achievement of treatment targets with apremilast
Psoriatic Arthritis ICYMI
Meta-analysis evaluates impact of bDMARD on QoL in PsA
Psoriatic Arthritis ICYMI
Secukinumab safe and effective as a first-line biologic for PsA
Psoriatic Arthritis ICYMI
IL-22 may serve as a biomarker of response to TNFi and IL-17i in PsA
Psoriatic Arthritis ICYMI
Abortion debate may affect Rx decisions for pregnant women
Psoriatic Arthritis ICYMI
Commentary: Factors in Psoriatic Arthritis Development and Treatment Response, June 2022
Psoriatic Arthritis ICYMI
Serum brodalumab levels linked with treatment outcomes in patients with psoriasis
Psoriatic Arthritis ICYMI
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
Psoriatic Arthritis ICYMI
Biologics, Women, and Pregnancy: What’s Known?
Psoriatic Arthritis ICYMI
Psoriatic Arthritis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge